Severe acute respiratory syndrome coronavirus (SARS-CoV) is an emerging pathogen responsible for considerable morbidity and mortality worldwide, yet little is known regarding the molecular basis for its pathogenesis. The most significant organ system affected in fatal SARS cases is the respiratory tract. The cynomolgus macaque model best replicates the pulmonary pathogenesis associated with human SARS and was used to prove that SARS-CoV is the primary etiologic agent of SARS, and that type-1 and -2 pneumocytes may be important target cells for SARS-CoV. Our overall goal is to increase our knowledge of SARS-CoV pulmonary pathogenesis.
In Specific Aim 1 we will evaluate the pathogenesis of SARS lung disease expanding upon the macaque model. We intend to refine identification of 'target cells permissive for SARS-CoV and possible changes in their distribution at different times after infection. The role of age and immunosuppression, important host factors that increase the severity SARS, will be examined by comparing the development of SARS in macaques of different ages, or treated with different levels of corticosteroids. We will build on the macaque model to include the use of infectious molecularly cloned wild-type SARS-CoV and SARS-CoV containing mutations in specific accessory genes that may contribute to virulence.
Specific Aim 2 will focus on the establishment of an appropriate cell culture system in which to evaluate the cellular response to wild-type and engineered SARS-CoV. This will include studies with human pneumocytes and small airway epithelial cells. We also will attempt to infect lung A549 cells and macaques primary macrophages and dendritic cells. Finally, Specific Aim 3 will determine molecular mechanisms and pathogenic signatures of SARS using global gene expression analysis and functional genomics. We will use oligonucleotide microarrays and sophisticated information technologies to examine gene expression changes in response to SARS-CoV infection. Experiments will be performed using RNA isolated from in vitro infections and from cells and tissues from experimentally infected macaques. Collectively, data obtained from the macaque model, cell culture systems, and gene expression analyses should provide new insights into the pathogenesis of SARS, aid in the development of diagnostic and prognostic assays, and identify novel targets for preventive or therapeutic intervention.

National Institute of Health (NIH)
National Heart, Lung, and Blood Institute (NHLBI)
Research Project (R01)
Project #
Application #
Study Section
Lung Cellular, Molecular, and Immunobiology Study Section (LCMI)
Program Officer
Peavy, Hannah H
Project Start
Project End
Budget Start
Budget End
Support Year
Fiscal Year
Total Cost
Indirect Cost
University of Washington
Schools of Medicine
United States
Zip Code
Smits, Saskia L; van den Brand, Judith M A; de Lang, Anna et al. (2011) Distinct severe acute respiratory syndrome coronavirus-induced acute lung injury pathways in two different nonhuman primate species. J Virol 85:4234-45
Tisoncik, Jennifer R; Katze, Michael G (2010) What is systems biology? Future Microbiol 5:139-41
Zornetzer, Gregory A; Frieman, Matthew B; Rosenzweig, Elizabeth et al. (2010) Transcriptomic analysis reveals a mechanism for a prefibrotic phenotype in STAT1 knockout mice during severe acute respiratory syndrome coronavirus infection. J Virol 84:11297-309
Smits, Saskia L; de Lang, Anna; van den Brand, Judith M A et al. (2010) Exacerbated innate host response to SARS-CoV in aged non-human primates. PLoS Pathog 6:e1000756
Walters, Kathie-Anne; Katze, Michael G (2009) Using high-throughput genomics to study hepatitis C: what determines the outcome of infection? Antiviral Res 81:198-208
Chan, Eric Y; Korth, Marcus J; Katze, Michael G (2009) Decoding the multifaceted HIV-1 virus-host interactome. J Biol 8:84
Rockx, Barry; Baas, Tracey; Zornetzer, Gregory A et al. (2009) Early upregulation of acute respiratory distress syndrome-associated cytokines promotes lethal disease in an aged-mouse model of severe acute respiratory syndrome coronavirus infection. J Virol 83:7062-74
Haagmans, Bart L; Andeweg, Arno C; Osterhaus, Albert D M E (2009) The application of genomics to emerging zoonotic viral diseases. PLoS Pathog 5:e1000557
Walters, Kathie-Anne; Syder, Andrew J; Lederer, Sharon L et al. (2009) Genomic analysis reveals a potential role for cell cycle perturbation in HCV-mediated apoptosis of cultured hepatocytes. PLoS Pathog 5:e1000269
de Lang, Anna; Baas, Tracey; Smits, Saskia L et al. (2009) Unraveling the complexities of the interferon response during SARS-CoV infection. Future Virol 4:71-78

Showing the most recent 10 out of 18 publications